The soluble VE-cadherin has already been recognized as a marker of different vascular pathologies including atherosclerosis, rheumatoid arthritis and more recently in Obstructive Sleep Apnea Syndrome [32,33,34]. This evidence concerns the gene CDH5 and atherosclerosis.